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Abstract
© 2016 American Association for Cancer Research.Therapy resistance and poor outcome in
prostate  cancer  is  associated  with  increased  expression  of  cyclin  D1.  Androgens
promoteDNAdouble-strand break repair to reduceDNAdamage, and cyclin D1 was also shown to
enhance DNA damage repair (DDR). In this study, we investigated the significance of cyclin D1
in androgen-induced DDR using established prostate cancer cells and prostate tissues from
cyclin D1 knockout mice. We demonstrate that endogenous cyclin D1 further diminished the
dihydrotestosterone (DHT)-dependent reduction of γH2AX foci in vitro. We also show that cyclin
D1 was required for the androgen-dependent DNA damage response both in vitro and in vivo.
Furthermore, cyclin D1 was required for androgenenhanced DDR and radioresistance of prostate
cancer cells. Moreover, microarray analysis of primary prostate epithelial cells from cyclin D1-
deficient and wild-type mice demonstrated that most of the DHT-dependent gene expression
changes  are  also  cyclin  D1  dependent.  Collectively,  our  findings  suggest  that  the
hormonemediated recruitment of cyclin D1 to sites of DDR may facilitate the resistance of
prostate  cancer  cells  to  DNA  damage  therapies  and  highlight  the  need  to  explore  other
therapeutic approaches in prostate cancer to prevent or overcome drug resistance.
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